KPT-330 Plus RICE for Relapsed/Refractory Aggressive B-Cell Lymphoma

NCT02471911 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B-Cell Lymphoma

Interventions

DRUG: KPT-330
DRUG: Rituximab
DRUG: Etoposide
DRUG: Carboplatin
DRUG: Ifosfamide
DRUG: Dexamethasone

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]
[object Object]
[object Object]